The Enterprise Value as of November 2024 (TTM) for AgeX Therapeutics, Inc. (AGE) is 19.70M

According to AgeX Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 19.70M. This represents a change of -41.99% compared to the average of 33.95M of the last 4 quarters.

AgeX Therapeutics, Inc. (AGE) Historical Enterprise Value (quarterly & annually)

How has AGE Enterprise Value performed in the past?

The mean historical Enterprise Value of AgeX Therapeutics, Inc. over the last ten years is 61.26M. The current 19.70M Enterprise Value has changed 3.12% with respect to the historical average. Over the past ten years (40 quarters), AGE's Enterprise Value was at its highest in in the March 2019 quarter at 134.56M. The Enterprise Value was at its lowest in in the March 2018 quarter at 0.

AgeX Therapeutics, Inc. (AGE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AgeX Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AgeX Therapeutics, Inc. (AGE) Average Enterprise Value

How has AGE Enterprise Value performed in the past?

The current Enterprise Value of AgeX Therapeutics, Inc. (AGE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

AgeX Therapeutics, Inc. (AGE) Enterprise Value vs. Peers

How is AGE’s Enterprise Value compared to its peers?

AgeX Therapeutics, Inc.’s Enterprise Value is less than MAIA Biotechnology, Inc. (41.04M), less than Larimar Therapeutics, Inc. (363.34M), greater than Graphite Bio, Inc. (-15007658.00), less than Lyra Therapeutics, Inc. (23.90M), less than Lineage Cell Therapeutics, Inc. (70.15M), less than Cadrenal Therapeutics, Inc. Common Stock (20.50M), less than ImmuCell Corporation (44.61M), less than Oxford Nanopore Technologies plc (1.23B), less than Praxis Precision Medicines, Inc. (0), less than Foghorn Therapeutics Inc. (1.22B), less than Synaptogenix, Inc. (417.24M), greater than Invivyd, Inc. (-16101194.00), greater than Biohaven Pharmaceutical Holding Company Ltd. (-21337338.00), less than Immunome, Inc. (4.54B), less than Inhibrx Biosciences, Inc. (459.83M), greater than Icosavax, Inc. (9.32M), less than null (713.87M),

Build a custom stock screener for AgeX Therapeutics, Inc. (AGE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AgeX Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AgeX Therapeutics, Inc. (AGE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AgeX Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.